BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 33472690)

  • 1. Differential effects of chronic immunosuppression on behavioral, epigenetic, and Alzheimer's disease-associated markers in 3xTg-AD mice.
    Kapadia M; Mian MF; Ma D; Hutton CP; Azam A; Narkaj K; Cao C; Brown B; Michalski B; Morgan D; Forsythe P; Zovkic IB; Fahnestock M; Sakic B
    Alzheimers Res Ther; 2021 Jan; 13(1):30. PubMed ID: 33472690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sex-Dependent Differences in Spontaneous Autoimmunity in Adult 3xTg-AD Mice.
    Kapadia M; Mian MF; Michalski B; Azam AB; Ma D; Salwierz P; Christopher A; Rosa E; Zovkic IB; Forsythe P; Fahnestock M; Sakic B
    J Alzheimers Dis; 2018; 63(3):1191-1205. PubMed ID: 29710702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of a 3xTg-AD mouse model of Alzheimer's disease with the senescence accelerated mouse prone 8 (SAMP8) background.
    Virgili J; Lebbadi M; Tremblay C; St-Amour I; Pierrisnard C; Faucher-Genest A; Emond V; Julien C; Calon F
    Synapse; 2018 Apr; 72(4):. PubMed ID: 29341269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroprotective Effect of SLM, a Novel Carbazole-Based Fluorophore, on SH-SY5Y Cell Model and 3xTg-AD Mouse Model of Alzheimer's Disease.
    Wu X; Kosaraju J; Zhou W; Tam KY
    ACS Chem Neurosci; 2017 Mar; 8(3):676-685. PubMed ID: 28032988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fyn knock-down increases Aβ, decreases phospho-tau, and worsens spatial learning in 3×Tg-AD mice.
    Minami SS; Clifford TG; Hoe HS; Matsuoka Y; Rebeck GW
    Neurobiol Aging; 2012 Apr; 33(4):825.e15-24. PubMed ID: 21741124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alcohol drinking exacerbates neural and behavioral pathology in the 3xTg-AD mouse model of Alzheimer's disease.
    Hoffman JL; Faccidomo S; Kim M; Taylor SM; Agoglia AE; May AM; Smith EN; Wong LC; Hodge CW
    Int Rev Neurobiol; 2019; 148():169-230. PubMed ID: 31733664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of CX3CR1 and Fractalkine Chemokines in Amyloid Beta Clearance and p-Tau Accumulation in Alzheimer's Disease (AD) Rodent Models: Is Fractalkine a Systemic Biomarker for AD?
    Merino JJ; Muñetón-Gómez V; Alvárez MI; Toledano-Díaz A
    Curr Alzheimer Res; 2016; 13(4):403-12. PubMed ID: 26567742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of the superoxide dismutase/catalase mimetic EUK-207 in a mouse model of Alzheimer's disease: protection against and interruption of progression of amyloid and tau pathology and cognitive decline.
    Clausen A; Xu X; Bi X; Baudry M
    J Alzheimers Dis; 2012; 30(1):183-208. PubMed ID: 22406441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of PLK2 activity affects APP and tau pathology and improves synaptic content in a sex-dependent manner in a 3xTg mouse model of Alzheimer's disease.
    Martínez-Drudis L; Sheta R; Pellegrinato R; Loukili S; Tremblay C; Calon F; Rivest S; Oueslati A
    Neurobiol Dis; 2022 Oct; 172():105833. PubMed ID: 35905928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transgenic autoinhibition of p21-activated kinase exacerbates synaptic impairments and fronto-dependent behavioral deficits in an animal model of Alzheimer's disease.
    Bories C; Arsenault D; Lemire M; Tremblay C; De Koninck Y; Calon F
    Aging (Albany NY); 2017 May; 9(5):1386-1403. PubMed ID: 28522792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunotherapy to improve cognition and reduce pathological species in an Alzheimer's disease mouse model.
    Herline K; Prelli F; Mehta P; MacMurray C; Goñi F; Wisniewski T
    Alzheimers Res Ther; 2018 Jun; 10(1):54. PubMed ID: 29914551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ca2+-permeable TRPV1 pain receptor knockout rescues memory deficits and reduces amyloid-β and tau in a mouse model of Alzheimer's disease.
    Kim J; Lee S; Kim J; Ham S; Park JHY; Han S; Jung YK; Shim I; Han JS; Lee KW; Kim J
    Hum Mol Genet; 2020 Jan; 29(2):228-237. PubMed ID: 31814000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sex Differences in Neuropathology and Cognitive Behavior in APP/PS1/tau Triple-Transgenic Mouse Model of Alzheimer's Disease.
    Yang JT; Wang ZJ; Cai HY; Yuan L; Hu MM; Wu MN; Qi JS
    Neurosci Bull; 2018 Oct; 34(5):736-746. PubMed ID: 30099679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoimmune manifestations in the 3xTg-AD model of Alzheimer's disease.
    Marchese M; Cowan D; Head E; Ma D; Karimi K; Ashthorpe V; Kapadia M; Zhao H; Davis P; Sakic B
    J Alzheimers Dis; 2014; 39(1):191-210. PubMed ID: 24150111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Age and sex differences in motivation and spatial working memory in 3xTg-AD mice in the Hebb-Williams maze.
    Fertan E; Wong AA; Vienneau NA; Brown RE
    Behav Brain Res; 2019 Sep; 370():111937. PubMed ID: 31121220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ultrasound with microbubbles improves memory, ameliorates pathology and modulates hippocampal proteomic changes in a triple transgenic mouse model of Alzheimer's disease.
    Shen Y; Hua L; Yeh CK; Shen L; Ying M; Zhang Z; Liu G; Li S; Chen S; Chen X; Yang X
    Theranostics; 2020; 10(25):11794-11819. PubMed ID: 33052247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physical exercise protects against Alzheimer's disease in 3xTg-AD mice.
    García-Mesa Y; López-Ramos JC; Giménez-Llort L; Revilla S; Guerra R; Gruart A; Laferla FM; Cristòfol R; Delgado-García JM; Sanfeliu C
    J Alzheimers Dis; 2011; 24(3):421-54. PubMed ID: 21297257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective effect of exercise training against the progression of Alzheimer's disease in 3xTg-AD mice.
    Kim D; Cho J; Kang H
    Behav Brain Res; 2019 Nov; 374():112105. PubMed ID: 31325514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early Intervention with a Multi-Ingredient Dietary Supplement Improves Mood and Spatial Memory in a Triple Transgenic Mouse Model of Alzheimer's Disease.
    Hutton CP; Lemon JA; Sakic B; Rollo CD; Boreham DR; Fahnestock M; Wojtowicz JM; Becker S
    J Alzheimers Dis; 2018; 64(3):835-857. PubMed ID: 29914019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tau passive immunization inhibits not only tau but also Aβ pathology.
    Dai CL; Tung YC; Liu F; Gong CX; Iqbal K
    Alzheimers Res Ther; 2017 Jan; 9(1):1. PubMed ID: 28073379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.